636 related items for PubMed ID: 20491705
1. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[Abstract] [Full Text] [Related]
2. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
3. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Apr; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
4. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL.
Pediatr Allergy Immunol; 2007 Jun; 18(4):354-9. PubMed ID: 17584314
[Abstract] [Full Text] [Related]
5. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[Abstract] [Full Text] [Related]
6. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
7. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
8. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Aug; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
9. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Aug; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
10. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
[Abstract] [Full Text] [Related]
11. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
[Abstract] [Full Text] [Related]
12. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
[Abstract] [Full Text] [Related]
13. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
J Formos Med Assoc; 2016 May 27; 115(5):350-5. PubMed ID: 25910931
[Abstract] [Full Text] [Related]
14. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
15. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
Int Immunopharmacol; 2020 Dec 21; 89(Pt A):107037. PubMed ID: 33242833
[Abstract] [Full Text] [Related]
16. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
Hashimoto I.
Pediatr Int; 2019 Jul 21; 61(7):641-646. PubMed ID: 31132210
[Abstract] [Full Text] [Related]
17. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Jul 21; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
18. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 21; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
19. Identifying Patients With Kawasaki Disease Safe for Early Discharge: Development of a Risk Prediction Model at a US Children's Hospital.
Hester GZ, Watson D, Nickel AJ, Ryan N, Jepson B, Gray J, Bergmann KR.
Hosp Pediatr; 2019 Oct 21; 9(10):749-756. PubMed ID: 31501220
[Abstract] [Full Text] [Related]
20. Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study.
Yan Y, Qiao L, Hua Y, Shao S, Zhang N, Wu M, Liu L, Zhou K, Liu X, Wang C.
Pediatr Rheumatol Online J; 2021 Sep 25; 19(1):147. PubMed ID: 34563210
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
